全文获取类型
收费全文 | 15667篇 |
免费 | 859篇 |
国内免费 | 178篇 |
专业分类
耳鼻咽喉 | 133篇 |
儿科学 | 304篇 |
妇产科学 | 144篇 |
基础医学 | 1785篇 |
口腔科学 | 253篇 |
临床医学 | 875篇 |
内科学 | 5075篇 |
皮肤病学 | 369篇 |
神经病学 | 966篇 |
特种医学 | 588篇 |
外科学 | 2681篇 |
综合类 | 61篇 |
一般理论 | 3篇 |
预防医学 | 293篇 |
眼科学 | 427篇 |
药学 | 855篇 |
中国医学 | 33篇 |
肿瘤学 | 1859篇 |
出版年
2023年 | 141篇 |
2022年 | 105篇 |
2021年 | 439篇 |
2020年 | 301篇 |
2019年 | 406篇 |
2018年 | 422篇 |
2017年 | 341篇 |
2016年 | 420篇 |
2015年 | 441篇 |
2014年 | 597篇 |
2013年 | 698篇 |
2012年 | 1177篇 |
2011年 | 1310篇 |
2010年 | 760篇 |
2009年 | 573篇 |
2008年 | 987篇 |
2007年 | 1145篇 |
2006年 | 1062篇 |
2005年 | 1050篇 |
2004年 | 965篇 |
2003年 | 887篇 |
2002年 | 918篇 |
2001年 | 146篇 |
2000年 | 107篇 |
1999年 | 124篇 |
1998年 | 168篇 |
1997年 | 159篇 |
1996年 | 120篇 |
1995年 | 117篇 |
1994年 | 96篇 |
1993年 | 91篇 |
1992年 | 60篇 |
1991年 | 49篇 |
1990年 | 47篇 |
1989年 | 46篇 |
1988年 | 24篇 |
1987年 | 26篇 |
1986年 | 17篇 |
1985年 | 17篇 |
1984年 | 22篇 |
1983年 | 13篇 |
1982年 | 16篇 |
1981年 | 19篇 |
1980年 | 16篇 |
1979年 | 7篇 |
1977年 | 9篇 |
1976年 | 6篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1971年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Norio Itokawa Masanori Atsukawa Akihito Tsubota Noritomo Shimada Hidenori Toyoda Koichi Takaguchi Atsushi Hiraoka Tomonori Senoh Mai Koeda Yuji Yoshida Tomomi Okubo Taeang Arai Korenobu Hayama Ai Nakagawa-Iwashita Chisa Kondo Katsuhiko Iwakiri 《Internal medicine (Tokyo, Japan)》2021,60(4):507
Objective Pegylated-interferon monotherapy is the standard treatment for patients with chronic hepatitis B; however, the factors associated with its therapeutic effects remain unclear. Methods Patients with chronic hepatitis B were treated with pegylated interferon α-2a for 48 weeks. We evaluated the kinetics of hepatitis B surface antigen (HBsAg) during treatment and follow-up periods and the factors associated with an HBsAg response (defined as a change in HBsAg of ≥-1 log IU/mL from baseline). Results The study population comprised 50 patients. The median baseline levels of hepatitis B virus DNA and HBsAg were 5.00 and 3.40 log IU/mL. The median values of HBsAg reduction from baseline were -0.44 (n=48), -0.41 (n=40), and -0.68 (n=11) log IU/mL at the end of treatment and at 48 and 144 weeks post-treatment, respectively. The rates of HBsAg response were 24.0% and 22.5% at the end of treatment and at 48 weeks post-treatment, respectively. A multivariate analysis identified HBsAg <3.00 log IU/mL as an independent baseline factor contributing to the HBsAg response at the end of treatment and 48 weeks post-treatment (p=1.07×10-2 and 4.42×10-2, respectively). There were significant differences in the reduction of the HBsAg levels at 12 weeks of treatment and in the incidence of serum ALT increase during treatment between patients with and without an HBsAg response. Conclusion These findings suggest that the baseline HBsAg level, HBsAg kinetics at 12 weeks of treatment, and ALT increase during treatment are important factors contributing to the HBsAg response in pegylated interferon α-2a monotherapy for patients with chronic hepatitis B. 相似文献
4.
5.
Atsushi Tanikawa Satoshi Seki Takuya Yasuda Eiju Hasegawa 《The American journal of emergency medicine》2019,37(9):1809.e1-1809.e3
Half-life of the antipsychotic vegetamin is very long, partially due to the presence of phenobarbital, and mortality due to phenobarbital poisoning is high. Here, we present the case of a 22-year-old female admitted to the emergency department with disturbed consciousness due to vegetamin overdose. Her blood phenobarbital level was elevated to 123 μg/ml. Phenobarbital undergoes enterohepatic circulation, and its retention in the intestine causes its blood levels to remain sustained. The utility of hemodialysis for drug poisoning has been previously reported; however, its efficiency is not yet established and its efficacy is low for drugs with long half-lives such as phenobarbital. Therefore, we performed a two-tube approach to adsorb phenobarbital in the intestines with activated charcoal delivered via a gastric tube and to remove the phenobarbital-adsorbed activated charcoal using whole bowel irrigation via an ileus tube 2 h later. The patient successfully eliminated the charcoal via stool, the blood phenobarbital level decreased drastically without hemodialysis, and the clinical course improved. We propose that this two-tube approach is suitable for treatment of poisoning with drugs that undergo enterohepatic circulation and have long half-lives. 相似文献
6.
7.
8.
Tetsuo Mitsui Naoto Fujita Yuhki Koga Reiji Fukano Tomoo Osumi Asahito Hama Katsuyoshi Koh Harumi Kakuda Masami Inoue Takahiro Fukuda Hiromasa Yabe Junko Takita Akira Shimada Yoshiko Hashii Atsushi Sato Yoshiko Atsuta Yoshinobu Kanda Junji Suzumiya Ryoji Kobayashi 《Pediatric blood & cancer》2020,67(4)
9.